|
SETD5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.477400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.514300E-02 |
| Normal-vs-Stage2 |
4.833900E-02 |
| Normal-vs-Stage3 |
8.411800E-04 |
| Normal-vs-Stage4 |
4.899600E-02 |
| Stage1-vs-Stage2 |
5.068000E-01 |
| Stage1-vs-Stage3 |
2.923800E-02 |
| Stage1-vs-Stage4 |
5.433600E-01 |
| Stage2-vs-Stage3 |
3.824800E-01 |
| Stage2-vs-Stage4 |
9.537400E-01 |
| Stage3-vs-Stage4 |
3.315000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.109970E-02 |
| Normal-vs-AfricanAmerican |
6.247600E-01 |
| Normal-vs-Asian |
1.881550E-01 |
| Caucasian-vs-AfricanAmerican |
3.143200E-01 |
| Caucasian-vs-Asian |
5.488200E-01 |
| AfricanAmerican-vs-Asian |
6.208400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.845600E-02 |
| Normal-vs-Female |
6.764000E-03 |
| Male-vs-Female |
8.017400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.314790E-01 |
| Normal-vs-Age(41-60Yrs) |
8.463200E-03 |
| Normal-vs-Age(61-80Yrs) |
3.199200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.243600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.313000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.010500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.352200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.653200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.905800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.805200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.835800E-04 |
| Classical-VS-Follicular |
7.735000E-03 |
| Classical-VS-Other |
4.143200E-01 |
| Classical-VS-Normal |
2.225000E-01 |
| Tall-VS-Follicular |
3.866200E-01 |
| Tall-VS-Other |
4.390600E-01 |
| Tall-VS-Normal |
2.222000E-04 |
| Follicular-VS-Other |
8.465800E-01 |
| Follicular-VS-Normal |
1.941240E-03 |
| Other-VS-Normal |
1.693010E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.044900E-03 |
| Normal-vs-N1 |
2.214000E-01 |
| N0-vs-N1 |
2.911800E-01 |
|
|
